NUTX
Nutex Health Inc. · Healthcare · Medical Care Facilities
Last
$105.37
+$3.60 (+3.54%) 4:00 PM ET
After hours $105.59 +$0.23 (+0.21%) 2:37 AM ET
Prev close $101.76
Open $103.30
Day high $109.04
Day low $101.24
Volume 246,560
Avg vol 222,181
Mkt cap
$704.15M
P/E ratio
10.81
FY Revenue
$875.26M
EPS
9.75
Gross Margin
100.00%
Sector
Healthcare
AI report sections
NUTX
Nutex Health Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+36% (Above avg)
Vol/Avg: 1.36×
RSI
49.51 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.13 (Weak)
MACD: -0.02 Signal: 0.11
Short-Term
+1.41 (Strong)
MACD: 0.91 Signal: -0.49
Long-Term
+1.96 (Strong)
MACD: -5.32 Signal: -7.28
Intraday trend score 51.00

Latest news

NUTX 12 articles Positive: 0 Neutral: 1 Negative: 11
Negative GlobeNewswire Inc. • Block & Leviton Llp
$ALDX ALERT: Aldeyra Therapeutics, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Block & Leviton is investigating multiple companies for securities fraud. Aldeyra Therapeutics (ALDX) shares fell 65% after the FDA rejected its reproxalap drug application for dry eye disease, citing failure to demonstrate efficacy. The firm is also investigating Eos Energy Enterprises (EOSE) and Nutex Health (NUTX) for potential securities violations. Investors who have lost money are encouraged to contact the law firm.

ALDX EOSE NUTX securities fraud FDA rejection drug efficacy investor losses class action lawsuit
Sentiment note

Under investigation for potential securities fraud, suggesting investor losses and regulatory concerns

Negative GlobeNewswire Inc. • Lowey Dannenberg P.C.
Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Law firm Lowey Dannenberg is investigating Nutex Health, Inc. (NUTX) for potential federal securities law violations after the company's stock fell over 24% on March 6, 2026. Nutex disclosed a $55 million cumulative true-up related to 18,950 arbitration claims deemed ineligible under the Independent Dispute Resolution process. The firm is seeking investors with losses exceeding $50,000.

NUTX securities investigation federal securities laws stock decline arbitration claims Independent Dispute Resolution class action lawsuit investor losses
Sentiment note

Company experienced a 24% stock price decline following disclosure of a $55 million charge related to ineligible arbitration claims, and is now subject to a securities investigation for potential violations of federal securities laws.

Negative Benzinga • Prnewswire
NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Nutex Health Inc. following a Blue Orca Capital report alleging improper billing practices, which caused the company's stock to drop 10.1%.

NUTX fraud investigation securities law shareholder rights billing practices
Sentiment note

The article describes an ongoing investigation into potential fraudulent statements and misleading practices, with a report suggesting improper billing activities that caused a significant stock price decline

Negative GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.
NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Law firm investigating potential claims against Nutex Health Inc. for allegedly making false and misleading statements about business operations, financial reporting, and engagement with HaloMD during August 2024-2025.

NUTX securities class action fiduciary duties financial reporting fraud allegations
Sentiment note

Allegations of fraudulent conduct, misleading financial statements, improper stock compensation calculations, and potential inability to file timely SEC reports suggest significant corporate governance and financial reporting issues

Negative Benzinga • Business Wire
Deadline Soon: Nutex Health Inc. (NUTX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Law Offices of Frank R. Cruz is alerting Nutex Health shareholders about an upcoming October 21, 2025 deadline to participate in a securities fraud class action lawsuit, alleging the company made misleading statements about its business operations and financial reporting.

NUTX securities fraud class action lawsuit financial reporting stock compensation arbitration
Sentiment note

The article details multiple allegations of fraudulent conduct, including misleading investors about revenue sources, internal control weaknesses, improper stock compensation calculations, and potential inability to file timely financial reports. Stock price drops of 10.1% and 16.4% further indicate significant investor concerns.

Negative Benzinga • Prnewswire
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is pursuing a class action lawsuit against Nutex Health Inc. for alleged securities fraud, claiming the company made false and misleading statements between August 2024 and August 2025.

NUTX securities fraud lawsuit class action investor rights
Sentiment note

The company is accused of engaging in a coordinated fraud scheme with HaloMD, making false statements about revenue, internal controls, and stock-based compensation, which led to investor damages

Negative GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Nutex Health Inc. alleging fraudulent financial practices, misleading statements about revenues, internal control weaknesses, and improper financial reporting during August 2024-2025.

NUTX class action securities fraud financial misrepresentation investor lawsuit
Sentiment note

Lawsuit alleges multiple serious financial misconduct issues including fraudulent revenue generation, misrepresentation of internal controls, improper compensation classification, and potential inability to file timely SEC reports

Negative GlobeNewswire Inc. • Hagens Berman
NUTX 3-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman

Nutex Health is facing a class-action lawsuit alleging fraudulent billing practices with third-party firm HaloMD, artificially inflating revenues through questionable insurance arbitration claims and misrepresenting financial statements.

NUTX securities fraud arbitration financial misrepresentation short-seller report
Sentiment note

Accused of systematic revenue inflation, misleading investors, misclassifying financial obligations, facing potential legal damages, and experiencing significant stock price drops after allegations

Negative GlobeNewswire Inc. • The Gross Law Firm
Shareholders of Nutex Health Inc. Should Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights – NUTX

Shareholders of Nutex Health Inc. are advised of a potential class action lawsuit alleging fraudulent financial practices and misleading statements during the period of August 8, 2024 to August 14, 2025.

NUTX securities lawsuit class action financial fraud shareholder rights
Sentiment note

The allegations include multiple claims of fraudulent conduct, including misleading financial statements, improper compensation calculations, and potential inability to file timely SEC reports, which suggest significant corporate governance issues

Negative GlobeNewswire Inc. • Hagens Berman
NUTX 5-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman

Nutex Health is facing a class-action lawsuit alleging fraudulent billing practices with third-party firm HaloMD, artificially inflating revenues through questionable insurance arbitration claims and misrepresenting financial statements.

NUTX lawsuit revenue inflation arbitration financial fraud short-seller report
Sentiment note

Accused of systematic billing fraud, misleading investors, stock price dropped significantly, facing legal action, and required financial statement restatement

Negative GlobeNewswire Inc. • Law Offices Of Howard G. Smith
DEADLINE ALERT for PUBM, SNAP, NUTX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

Law firm alerts shareholders about potential securities fraud class action lawsuits for PubMatic, Snap, and Nutex, with upcoming lead plaintiff filing deadlines in October 2025.

PUBM SNAP NUTX securities fraud class action shareholder lawsuit financial misconduct
Sentiment note

Allegations of fraudulent revenue generation, improper financial reporting, and overstating business prospects through potential insurance fraud schemes

Neutral GlobeNewswire Inc. • Gross Law Firm
Lost Money on Dow Inc.(DOW)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

The Gross Law Firm has issued a notice to Dow Inc. shareholders about a potential class action lawsuit alleging the company made false or misleading statements about its financial condition and ability to manage economic challenges during January 30 to July 23, 2025.

DOW NUTX TROX securities lawsuit class action shareholder notice financial disclosure
Sentiment note

Limited context provided, only mentioned in passing as another potential class action target

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal